Ngenla

Medicinal product

(Invented) name

Ngenla

Active substance (s)

Somatrogonas

Strength

60 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkštiklyje

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H01AC08, somatrogon

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2022-02-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled pen	1.2 ml
Somatrogonas	60 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108162	94266	1094266	užpildytas švirkštiklis	1,2 ml N1		Receptinis	EU/1/21/1617/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-02-14	Registruotas